Zimbabwe has rejected a substantial US healthcare agreement worth 367 million US dollars (£272m) over five years over the United States' insistence on confidential data.
This move came to light following a government memo from December was leaked, revealing that Head of State Emmerson Mnangagwa believed the arrangement was "skewed".
An official spokesperson has since stated that the United States was seeking genetic material for research and commercial purposes while was unwilling to share the benefits from any future medical innovations.
"We will now turn to the challenging and unfortunate process of ending our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy said the United States had donated more than $1.9bn for health programmes to Zimbabwe over the last two decades.
A doctors' association in Zimbabwe has called for continued negotiations to secure a agreement suitable to both sides so the country's vital HIV programme can be sustained.
Wider Context
Zimbabwe's decision comes after a comparable case in Kenya, where a court suspended a related health funding agreement following concerns were raised about the security of Kenyans' medical information.
After resuming office last year, US President Donald Trump has drastically cut foreign aid and shut down the key foreign aid agency.
The agency had managed assistance for the US government, but Trump claimed its spending was "inefficient" and his government was seeking direct bilateral deals to boost transparency and accountability.
As per statements, 16 African countries have to date signed similar agreements, constituting more than $18.3bn of fresh investment.
Specifics of the Rejected Deal
The money for Zimbabwe would have gone towards "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this cooperation would have delivered significant benefits for the people of Zimbabwe, especially the 1.2 million currently receiving HIV treatment through US-supported initiatives," Tremont commented.
However, government spokesperson Nick Mangwana argued the arrangement was "asymmetrical".
"Our nation was requested to surrender its genetic material and health information over an extended period, without any corresponding guarantee of access to any scientific breakthroughs – such as new medicines or tests – that might be developed from that shared data," his statement read.
"In essence, our country would provide the basic resources for scientific discovery with no certainty that the final treatments would be accessible to our citizens if a future disease outbreak emerge."
National Interest and International Frameworks
He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were undermining structures already established through the international organization.
Mangwana cited its Pathogen Access and Benefit Sharing scheme created to deal with future pandemics.
"This framework is designed to guarantee that when a country provides its information, the resulting advantages – such as vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the capability to develop them."
Zimbabwe's reservations regarding the US deal "should not be misconstrued as hostility towards the US," he added.
"We are open to continued dialogue with our US partners on how subsequent co-operation could be arranged in a way that honours the independence and dignity of both nations."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it understood the government's concerns, but urged that talks must proceed considering a large portion of the country's Aids initiatives were funded by international support.
"In cases where technical issues exist, including those involving information security or agreement terms, these can frequently be addressed through detailed discussion and mutually agreed protections," the group commented.
The situation highlights the continuing challenges between receiving vital international aid and safeguarding national sovereignty in an ever more data-driven world.